Key result
Anti-platelet autoantibodies occurring during valproate therapy are associated with peroperative bleeding and have GPIaIIa as a candidate target.
GPIaIIa is identified as a candidate target for anti-platelet autoantibodies during valproate therapy, which is associated with peroperative bleeding.
Answers are grounded in this paper and cite their sources.
May warrant perioperative platelet monitoring in valproate users; hypothesis-generating for GPIaIIa as autoantibody target.
GPIaIIa as a Candidate Target for Anti-platelet Autoantibody Occurring during Valproate Therapy and Associated with Peroperative Bleeding -
No takes yet. Share an insight, caveat, or question.
Masnou et al. (2000) studied this question. Anti-platelet autoantibodies occurring during valproate therapy are associated with peroperative bleeding and have GPIaIIa as a candidate target.
Synapse has enriched 10 related papers. Consider them for comparative context: